Environmental Risk Factors and Schizophrenia;Facteurs de risque environnementaux à la schizophrénie

Annales Medico-Psychologiques

Volumn 166, Issue 8, 2008, Pages 606-611

  Demily, C ^c   Thibaut, F ^a,b  

^a HÔPITAL CHARLES NICOLLE   (France)

^b CHS du Rouvray   (France)

^c INSTITUT DES SCIENCES COGNITIVES   (France)

Author keywords

Environment; Genetics; Neurodevelopment; Schizophrenia; Vulnerability

Indexed keywords

ARTICLE; CANNABIS ADDICTION; CLINICAL FEATURE; DISEASE PREDISPOSITION; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD INJURY; HEREDITY; HUMAN; IMMIGRANT; LABOR COMPLICATION; LOW BIRTH WEIGHT; MATERNAL DISEASE; MONOZYGOTIC TWINS; NUTRITIONAL DISORDER; ONSET AGE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL ASPECT; STRESS; SUBSTANCE ABUSE; SYMPTOMATOLOGY; URBAN AREA; WINTER;

EID: 52049094393     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amp.2006.09.016     Document Type: Article

References (39)

1. AbdelMalik P., Husted J., Chow E.W., and Basset A.S. Childhood head injury and expression of schizophrenia in multiply affected families. Arch. Gen. Psychiatry 60 (2003) 231-236
2. Adams W., Kendell R.E., Hare E.H., and Munk-Morgensen P. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br. J. Psychiatry 163 (1993) 522-534
3. Agerbo E., Byrne M., Eaton W.W., and Mortensen P.B. Marital and labor market status in the long run in schizophrenia. Arch. Gen. Psychiatry 61 (2004) 28-33
4. Aleman A., Kahn R.S., and Selten J.P. Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Arch. Gen. Psychiatry 60 (2003) 565-571
5. Block R.I., O'Leary D.S., Hichwa R.D., Augustinack J.C., Boles Ponto L.L., Ghoneim M.M., et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol. Bioch. Behavior 72 (2002) 237-250
6. Broome M.R., Woolley J.B., Tabraham P., Johns L.C., Bramon E., Murray G.K., et al. What causes the onset of psychosis?. Schizophr. Res. 79 (2005) 23-34
7. Brown A.S., Hooston J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 161 (2004) 889-895 (a)
8. Brown A.S., Begg M.D., Gravenstein S., Shaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the aetiology of schizophrenia. Arch. Gen. Psychiatry 61 (2004) 774-780 (b)
9. Byrne M., Agerbo E., Easton W.W., and Mortensen P.B. Parental socio-economic status and risk of first admission with schizophrenia - a Danish national register based study. Soc. Psychiatry Psychiatr. Epidemiol. 39 (2004) 87-96
10. Cannon M., and Clarke M.C. Risk for schizophrenia-broadening the concepts, pushing back the boundaries. Schizophr. Res. 79 (2005) 5-13
11. Cantor-Graae E., and Selten J.P. Schizophrenia and migration: A meta-analysis and review. Am. J. Psychiatry 162 (2005) 12-24
12. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H.L., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the cathecol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57 (2005) 1117-1127
13. Cyr M., Ghribi O., and Di Paolo T. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J. Neuroendocrinol. 12 (2000) 445-452
14. Di Maggio C., Martinez M., Menard J.F., Petit M., and Thibaut F. Evidence of a cohort effect for age at onset of schizophrenia. Am. J. Psychiatry 158 (2001) 489-492
15. Dupont A., Di Paolo T., Gagne B., and Barden N. Effects of chronic oestrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats. Neurosci. Lett. 22 (1981) 69-74
16. Egan M.F., Goldberg T.E., Kolachana B., Callicott J.M., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98 (2001) 6917-6922
17. Fellerhoff B., Laumbacher B., and Wank R. High risk of schizophrenia and other mental disorders associated with chlamydial infections: Hypothesis to combine drug treatment and adoptive immunotherapy. Med. Hypotheses 65 (2005) 243-252
18. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., and Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411 (2001) 86-89
19. Haouzir S., Petit M., and Thibaut F. Head trauma as a risk factor for schizophrenia. Schizophr. Res. 41 (2000) 72
20. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., and Wittchen H.U. Prospective cohort study of cannabis usse, and psychotic symptoms in young people. Br. J. Med. Available BMJ (2004)
21. Jockers-Scherubl M.C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsch J., Schureer F., et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci. Lett. 371 (2004) 79-83
22. Karege F., Schwald M., and Cisse M. Post-natal development profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328 (2002) 261-264
23. Mackay-Sim A., Feron F., Eyles D., Burne T., and Mc Grath J. Schizophrenia, vitamin D and brain development. Int. Rev. Neurobiol. 59 (2004) 351-380
24. McGrath J., Feron F.P., Burne T.H., Mackay-Sim A., and Eyles D.W. Vitamin D3-implications for brain development. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 557-560
25. McGrath J. Variations in the incidence of schizophrenia: Data versus dogma. Schizophr. Bull. 32 (2006) 195-197
26. McGrath J., Saha S., Lieberman D.E., and Buka S. Season of birth is associated with anthropometric and neurocognitive outcomes during infancy and childhood in a general population birth cohort. Schizophr. Res. 81 (2006) 91-100
27. Mino Y., and Oshima I. Seasonality of birth in patients with schizophrenia in Japan. Psychiatry Clin. Neurosci. 60 (2006) 249-252
28. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfahrt J., Ewald H., Mors O., et al. Effects of family history and place and season of birth on the risk of schizophrenia. New Engl J Med 340 (1999) 603-608
29. Opler M.G.A., and Susser E.S. Fetal environment and schizophrenia. Env. Health Per. 113 (2006) 1239-1242
30. Pistis M., Perra S., Pillolla G., Melis M., Muntoni A.L., and Gessa G.L. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rats midbrain dopamine neurons. Biol. Psychiatry 56 (2004) 86-94
31. Van Os J., Driesen G., and Gubther N. Neighbourhood variation in incidence of schizophrenia. Br. J. Psychiatry 176 (2000) 2243-2248
32. Van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R., and Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. Am. J. Epidemiol. 156 (2002) 319-327
33. Van Os J., Pedersen C.B., and Mortensen P.B. Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am. J. Psychiatry 161 (2004) 2312-2314
34. Verdoux H., Gindre C., Sorbara F., Tournier M., and Swendsen J.D. Effects of cannabis and psychosis vulnerability in daily life: An experience sampling test study. Psychol. Med. 33 (2003) 23-32
35. Verdoux H. Perinatal risk factors for schizophrenia: How specific are they?. Curr. Psychiatry Rep. 6 (2004) 162-167
36. Voldsgaard P., Schiffman J., Mednick S., Rodgers B., Christensen H., Bredkjaer S., et al. Accuracy of retrospective reports of infections during pregnancy. Int. J. Methods Psychiatr. Res. 11 (2002) 184-186
37. Walshe M., McDonald C., Taylor M., Zhao J., Sham P., Grech A., et al. Obstetric complications in patients with schizophrenia and their unaffected siblings. Eur. Psychiatry 20 (2005) 28-34
38. Weiser M., Reichenberg A., Rabinowitz J., Kaplan Z., Caspi A., Yasvizky R., et al. Self-reported drug abuse in male adolescent with behavioural disturbances, and follow-up for future schizophrenia. Biol. Psychiatry 54 (2004) 655-660
39. Weiser M., Davidson M., and Noy S. Comments on risk for schizophrenia. Schizophr. Res. 79 (2005) 15-21